Search
  • SBIJI Innovation

Biond Biologics Announces Poster Presentations at AACR 2020 Virtual AnnualMeeting

July 9, 2020


Published work highlights the preclinical development of BND-22, an anti-ILT2 multi-cell checkpoint inhibitor that enhances the anti-tumor activity of innate and adaptive immune cells Also, first publication of a regulatory mechanism of the CD28/B7 immune stimulatory pathway, identifying CD28 shedding as a potential novel target for cancer therapeutics

Read More




0 views

Recent Posts

See All

A Member firm of SBI Group, Japan

© 2020 SBI JI Innovation Advisory Ltd. All rights reserved